Synthetic Genomics, Archer Daniels Midland to Commercialize Omega-3 from Algae | GenomeWeb

NEW YORK (GenomeWeb) – Synthetic Genomics and Archer Daniels Midland today announced a deal to commercialize Omega-3 docosahexaenoic acid (DHA) from algae.

Typically found in fish and seafood products, DHA has been studied for the role it plays in brain, heart, and eye health. Extracting DHA directly from algae grown in fermentation tanks yields a "highly purified" form of DHA, which can be used as a dietary supplement for humans and in animal feed, the partners said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.